Glycosphingolipids and drug resistance

被引:83
作者
Gouaze-Andersson, Valerie [1 ]
Cabot, Myles C. [1 ]
机构
[1] St Johns Hlth Ctr, Dept Expt Therapeut, John Wayne Canc Inst, Santa Monica, CA 90404 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 2006年 / 1758卷 / 12期
基金
美国国家卫生研究院;
关键词
multidrug resistance; glycosphingolipids; glucosylceramide synthase; P-glycoprotein;
D O I
10.1016/j.bbamem.2006.08.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Drug resistance, an all too frequent characteristic of cancer, represents a serious barrier to successful treatment. Although many resistance mechanisms have been described, those that involve membrane-resident proteins belonging to the ABC (ATP binding cassette) transporter superfamily are of particular interest. In addition to cancer, the ABC transporter proteins are active in diseases such as malaria and leishmaniasis. A recent renaissance in lipid metabolism, specifically ceramide and sphingolipids, has fueled research and provided insight into the role of glycosphingolipids in multidrug resistance. This article reviews current knowledge on ceramide, glucosylceramide synthase and cerebrosides, and the relationship of these lipids to cellular response to anticancer agents. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:2096 / 2103
页数:8
相关论文
共 104 条
  • [1] IMPROVED INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE
    ABE, A
    INOKUCHI, J
    JIMBO, M
    SHIMENO, H
    NAGAMATSU, A
    SHAYMAN, JA
    SHUKLA, GS
    RADIN, NS
    [J]. JOURNAL OF BIOCHEMISTRY, 1992, 111 (02) : 191 - 196
  • [2] The role of arachidonic acid regulatory enzymes in colorectal disease
    Abir, F
    Alva, S
    Kaminski, DL
    Longo, WE
    [J]. DISEASES OF THE COLON & RECTUM, 2005, 48 (07) : 1471 - 1483
  • [3] Overcoming resistance to γ-rays in squamous carcinoma cells by poly-drug elevation of ceramide levels
    Alphonse, G
    Bionda, C
    Aloy, MT
    Ardail, D
    Rousson, R
    Rodriguez-Lafrasse, C
    [J]. ONCOGENE, 2004, 23 (15) : 2703 - 2715
  • [4] Effect of P-glycoprotein modulator, cyclosporin A, on the gastrointestinal excretion of irinotecan and its metabolite SN-38 in rats
    Arimori, K
    Kuroki, N
    Hidaka, M
    Iwakiri, T
    Yamasaki, K
    Okumura, M
    Ono, H
    Takamura, N
    Kikuchi, M
    Nakano, M
    [J]. PHARMACEUTICAL RESEARCH, 2003, 20 (06) : 910 - 917
  • [5] BARTLETT JG, 1998, HOPKINS HIV REP, V10, P8
  • [6] ABC transporters in lipid transport
    Borst, P
    Zelcer, N
    van Helvoort, A
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2000, 1486 (01): : 128 - 144
  • [7] CERAMIDE SYNTHASE MEDIATES DAUNORUBICIN-INDUCED APOPTOSIS - AN ALTERNATIVE MECHANISM FOR GENERATING DEATH SIGNALS
    BOSE, R
    VERHEIJ, M
    HAIMOVITZFRIEDMAN, A
    SCOTTO, K
    FUKS, Z
    KOLESNICK, R
    [J]. CELL, 1995, 82 (03) : 405 - 414
  • [8] P-GLYCOPROTEIN, MULTIDRUG-RESISTANCE AND TUMOR PROGRESSION
    BRADLEY, G
    LING, V
    [J]. CANCER AND METASTASIS REVIEWS, 1994, 13 (02) : 223 - 233
  • [9] Tamoxifen retards glycosphingolipid metabolism in human cancer cells
    Cabot, MC
    Giuliano, AE
    Volner, A
    Han, TY
    [J]. FEBS LETTERS, 1996, 394 (02) : 129 - 131
  • [10] INDUCTION OF MULTIDRUG RESISTANCE IN HUMAN-CELLS BY TRANSIENT EXPOSURE TO DIFFERENT CHEMOTHERAPEUTIC DRUGS
    CHAUDHARY, PM
    RONINSON, IB
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (08) : 632 - 639